6月1日，思摩尔国际盘中上涨3.96%，报9.46港元/股，成交额1462.35万港元。
消息面上，此前美国FDA首次批准非烟草口味电子烟通过PMTA审核，推动公司股价5月内累涨超20%，随后自5月14日起连续回调，成交持续缩量反映市场观望情绪浓厚。当前股价在经历多日获利了结后出现企稳反弹迹象。机构仍看好思摩尔国际中长期逻辑，认为其未成年人识别技术系FDA审批关键考量，核心客户产品及自主品牌有望加速获批，直接受益于合规市场复苏。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.